The European Society for Medical Oncology has welcomed the adoption of the Clinical Trials Regulation by the Council of the European Union and the European Parliament, which enters into force this week. The new clinical trial framework acknowledges the importance of using data stored for a clinical trial beyond the end of the study itself, for research purposes. Practically speaking, the Regulation states that when a patient gives his/her consent for a clinical trial, he/she can easily give a one-time consent for data to be used beyond the trial, for the purpose of medical research, still with the possibility to withdraw it at any time. Read more here.
No comments:
Post a Comment